Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
691 First-in-human trial of novel HBsAg-specific TCR T cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
